Tech Company Financing Transactions
Vedantra Pharmaceuticals Funding Round
On 8/4/2018, Vedantra Pharmaceuticals raised $14.5 million in investment from private investors.
Transaction Overview
Company Name
Announced On
8/4/2018
Transaction Type
Debt
Amount
$14,492,501
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 115 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1 Kendall Sq. Bldg. 1400 14303
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Not Recorded
Overview
Vedantra Pharmaceuticals is applying novel nanotechnology-based approaches to develop vaccines for infectious disease and cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Julian Adams
Co-Founder
Satish Jindal
Founder
Darrell Irvine
VP - R & D
Peter DeMuth
Browse more venture capital transactions:
Prev: 8/4/2018: Deezer venture capital transaction
Next: 8/4/2018: Independa venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs